However, in addition to decreasing hemorrhagic spots, BMSC treatment increases vascular endothelial growth factor expression and angiogenesis [27], which may lead to the marginally significant (p<0.08) reduction of hemorrhagic volume in treated T2DM rats at 5w after stroke, compared with the controls (Fig 1C). Here, VEGFA is linked to type 2 diabetes mellitus.